Lilly on Thursday reported fourth-quarter revenue of $13.53 billion, a steep 45% increase over the sum the Indianapolis-based drugmaker generated during the same period in 2023.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback